WELLS FARGO & COMPANY/MN - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 22 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q2 2022$179,000
-2.2%
193,0000.0%0.00%
Q1 2022$183,000
+3.4%
193,0000.0%0.00%
Q4 2021$177,000
+2.9%
193,0000.0%0.00%
Q3 2021$172,000
-84.0%
193,000
-83.8%
0.00%
Q2 2021$1,075,000
-12.1%
1,193,000
-4.6%
0.00%
Q1 2021$1,223,000
+3.6%
1,250,0000.0%0.00%
Q4 2020$1,180,000
-83.3%
1,250,000
-84.0%
0.00%
-100.0%
Q3 2020$7,058,000
+819.0%
7,800,000
+875.0%
0.00%
Q2 2020$768,000
-0.3%
800,0000.0%0.00%
Q1 2020$770,000
-4.1%
800,0000.0%0.00%
Q4 2019$803,000
+10.3%
800,0000.0%0.00%
Q3 2019$728,000
-15.8%
800,000
-20.0%
0.00%
Q2 2019$865,000
-12.2%
1,000,0000.0%0.00%
Q1 2019$985,000
-5.7%
1,000,0000.0%0.00%
Q4 2018$1,044,000
-12.1%
1,000,0000.0%0.00%
Q3 2018$1,188,000
+20.6%
1,000,0000.0%0.00%
Q2 2018$985,000
-3.1%
1,000,0000.0%0.00%
Q1 2018$1,017,0001,000,0000.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Context Capital Management, LLC 6,000,000$5,827,0003.55%
DeepCurrents Investment Group LLC 21,223,000$20,803,0001.80%
ZAZOVE ASSOCIATES LLC 19,230,000$18,725,0001.77%
Mohican Financial Management, LLC 500,000$494,0001.61%
Castle Creek Arbitrage, LLC 5,149,000$5,015,0001.47%
LINDEN ADVISORS LP 62,688,000$61,071,0001.40%
Verition Fund Management LLC 10,817,000$10,504,0000.41%
WOLVERINE ASSET MANAGEMENT LLC 24,100,000$23,451,0000.32%
Baupost Group 30,000,000$29,213,0000.24%
SSI INVESTMENT MANAGEMENT LLC 2,763,000$2,676,0000.22%
View complete list of THERAVANCE BIOPHARMA INC shareholders